|
Market Closed -
Japan Exchange
14:30:00 08/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 546.00 JPY | -5.70% |
|
-13.61% | - |
| 08-22 | Certain Common Stock of Innovacell Inc. are subject to a Lock-Up Agreement Ending on 22-AUG-2026. | CI |
| 08-06 | Innovacell Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 26.14B 165M 148M 138M 125M 236M 15.99B 237M 1.66B 647M 8.13B 621M 607M | P/E 2026 * |
-7.1x | P/E 2027 * | -6.7x |
|---|---|---|---|---|---|
| Enterprise Value | 26.14B 165M 148M 138M 125M 236M 15.99B 237M 1.66B 647M 8.13B 621M 607M | EV / Sales 2026 * |
26.1x | EV / Sales 2027 * | 24.3x |
| Free-Float |
51.11% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -5.70% | ||
| 1 week | -13.61% | ||
| Current month | -13.61% | ||
| 1 month | -3.19% | ||
| 3 months | +0.55% | ||
| 6 months | -35.15% |
| 1 week | 546 |  | 632 |
| 1 month | 519 | | 643 |
| Current year | 377 | | 1,248 |
| 1 year | 377 | | 1,248 |
| 3 years | 377 | | 1,248 |
| 5 years | 377 | | 1,248 |
| 10 years | 377 | | 1,248 |
| Manager | Title | Age | Since |
|---|---|---|---|
Colin Lee Novick
CEO | Chief Executive Officer | 45 | 01/03/2022 |
Jason Sieger
CEO | Chief Executive Officer | 44 | 01/03/2025 |
Yasushi Hosono
DFI | Director of Finance/CFO | 59 | 01/07/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Jason Sieger
BRD | Director/Board Member | 44 | 01/01/2021 |
Colin Lee Novick
BRD | Director/Board Member | 45 | 01/07/2021 |
| Director/Board Member | 57 | 01/04/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.70% | -13.61% | - | - | 165M | |
| +2.70% | +2.73% | +40.91% | +110.31% | 1,060B | |
| +1.44% | -2.38% | +36.83% | +63.95% | 623B | |
| +1.75% | +3.73% | +16.55% | +83.05% | 480B | |
| +0.60% | -1.73% | +62.98% | +37.46% | 352B | |
| -1.78% | +1.26% | +21.32% | +40.88% | 345B | |
| -1.36% | +0.24% | +11.12% | +34.28% | 274B | |
| -1.00% | -1.89% | -5.73% | +10.98% | 249B | |
| +2.60% | -2.00% | +39.77% | +54.44% | 223B | |
| +1.82% | -1.48% | +25.75% | +96.48% | 182B | |
| Average | -0.48% | -1.28% | +27.72% | +59.09% | 378.82B | |
| Weighted average by Cap. | -0.23% | +0.04% | +31.40% | +70.14% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1B 6.32M 5.65M 5.27M 4.79M 9.02M 612M 9.08M 63.34M 24.75M 311M 23.74M 23.22M | 1.08B 6.82M 6.09M 5.68M 5.16M 9.72M 659M 9.79M 68.28M 26.68M 335M 25.59M 25.04M |
| Net income | -3.46B -21.9M -19.56M -18.25M -16.58M -31.23M -2.12B -31.46M -219M -85.69M -1.08B -82.2M -80.43M | -3.81B -24.08M -21.51M -20.07M -18.23M -34.34M -2.33B -34.59M -241M -94.23M -1.18B -90.39M -88.44M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/10/26 | JP¥546.00 | -5.70% | 101,600 |
| 07/10/26 | JP¥579.00 | +0.52% | 73,700 |
| 06/10/26 | JP¥576.00 | -0.69% | 58,300 |
| 05/10/26 | JP¥580.00 | -3.65% | 68,900 |
| 02/10/26 | JP¥602.00 | -3.06% | 96,000 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 504A Stock
Select your edition
All financial news and data tailored to specific country editions
